Effects of ozonated autohemotherapy on the antioxidant capacity of Thoroughbred horses
Tsuzuki N, Endo Y, Kikkawa L, et al. Journal of Veterinary Medical Science, 2016.
- Study type
- Animal study
- Animals studied
- 10 animals
- Population
- Thoroughbred racehorses
- Published
- 2016, Journal of Veterinary Medical Science
- Identifiers
- PMID 26166812, DOI 10.1292/jvms.15-0225
What the authors reported
In 10 Thoroughbred horses, ozonated autohemotherapy raised a blood marker of antioxidant capacity (biological antioxidant potential) compared with a control group at 3 and 7 days after treatment.
What limits this result
Animal study, not human; measures a general antioxidant blood marker rather than any disease outcome, and does not test EBO2's continuous-filtration circuit.
How ozone acts on blood and cells, how blood filters work, and studies that measure markers in the blood rather than how patients fare. None of these shows whether EBO2 helps patients. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.
Where we cite this study
EBO2 (EBOO) for Athletes and Recovery: Hype, Anecdotes, and Evidence
What Bryce Harper's EBOO announcement, the WADA prohibited list, and the sparse ozone-and-performance research show about EBO2 (also called EBOO) for athletes.